HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Nuclear Factor 45 Protein

A protein subunit that takes part in forming nuclear factor 90 protein complexes.

Also Known As:

ILF2 Protein; NF45 Protein; Interleukin Enhancer Binding Factor 2

Networked: 13 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Transcription Factors: 38804
    - Nuclear Factor 90 Proteins: 26
      - Nuclear Factor 45 Protein: 13
        human ILF2 protein
        mouse Ilf2 protein
  - Carrier Proteins: 12999
    - RNA-Binding Proteins: 3262
      - Nuclear Factor 90 Proteins: 26
        Nuclear Factor 45 Protein: 13
        human ILF2 protein
        mouse Ilf2 protein

Experts

1.	Li, Hui: 2 articles (01/2022 - 08/2019)
2.	Jin, Jing: 2 articles (12/2019 - 01/2018)
3.	Wang, Wenbiao: 2 articles (12/2019 - 01/2018)
4.	Wu, Jianguo: 2 articles (12/2019 - 01/2018)
5.	Che, Yilei: 1 article (01/2022)
6.	Wu, Xiaozhen: 1 article (01/2022)
7.	Xuan, Bin: 1 article (01/2022)
8.	Zhang, Hui: 1 article (01/2022)
9.	Chang, Wei-Kuo: 1 article (11/2021)
10.	Feng, An-Chieh: 1 article (11/2021)

Related Diseases

1.	Infections 12/23/2019 - "In this study, we initially show that the interleukin enhancer-binding factor 2 (ILF2) reduces EV71 50% tissue culture infective dose (TCID50) and attenuates EV71 plaque-formation unit (PFU), thereby repressing EV71 infection. "
2.	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/01/2019 - "The results from the present study revealed that the transcription factor interleukin enhancer-binding factor 2 (ILF2) was highly expressed in non-small cell lung cancer (NSCLC) cell lines compared with in normal cell lines. "
3.	Neoplasms (Cancer) 11/01/2019 - "Interleukin enhancer binding factor 2 (ILF2) is upregulated in several malignancies, however, much remains unknown regarding ILF2 in small cell lung cancer (SCLC). " 01/01/2021 - "Interleukin enhancer binding factor 2 (ILF2) and ILF3, double-stranded RNA-binding proteins, have been reported to contribute to the occurrence and development of various types of malignancy. " 10/01/2020 - "Interleukin enhancer-binding factor 2 (ILF2) forms a heterodimer with interleukin enhancer-binding factor 3 (ILF3) via double-stranded RNA-binding motif and zinc finger associated domain and thus regulates gene expression and cancer cell growth. "
4.	Hepatocellular Carcinoma (Hepatoma) 11/01/2021 - "CRNDE-h transcript/miR-136-5p axis regulates interleukin enhancer binding factor 2 expression to promote hepatocellular carcinoma cell proliferation." 08/22/2016 - "Expression and Critical Role of Interleukin Enhancer Binding Factor 2 in Hepatocellular Carcinoma."
5.	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/01/2019 - "Interleukin enhancer binding factor 2 (ILF2) is upregulated in several malignancies, however, much remains unknown regarding ILF2 in small cell lung cancer (SCLC). "

Related Drugs and Biologics

1.	Transcription Factors (Transcription Factor)
2.	RNA-Binding Proteins (RNA-Binding Protein)
3.	Inflammasomes
4.	Nuclear Factor 90 Proteins
5.	Biomarkers (Surrogate Marker)
6.	Smoke
7.	Glycine Hydroxymethyltransferase (Serine Hydroxymethyltransferase)
8.	RNA (Ribonucleic Acid)
9.	Nicotine
10.	DNA (Deoxyribonucleic Acid)

Related Therapies and Procedures

1.	Neoadjuvant Therapy